Novo Nordisk creates new unit to ramp up use of artificial intelligence and digital tools in research
Pharmaceutical firm Novo Nordisk is establishing a new, global focus area, bringing AI and other digital tools to its research and early development. In time, the unit will employ ”several hundreds of people,” says the head of the unit.
by CHRISTOPHER DUE KARLSSON, translated by daniel pedersen
Digital opportunities will soon be playing a more active role in the research conducted by Denmark’s biggest pharmaceutical firm, Novo Nordisk, which is why the company is establishing a new, global focus area for this purpose.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lack of IT specialists could hamper life science growth
For subscribers
Novo Nordisk grants Taiwanese firm access to smart pen data
For subscribers
